Ood Bioprod Process 2003, 81:81?8. 31. St l K, Claesson M, Lilliehorn P, Lind H, B kstr K: The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int J Pharm 2002, 233:227?37. 32. Vehring R: Pharmaceutical particle engineering by way of spray drying. Pharm Res 2008, 25:999?022. 33. LechugaBallesteros D, Charan C, Stults CL, Stevenson CL, Miller DP, Vehring R, Tep V, Kuo MC: Trileucine improves aerosol overall performance and stability of spraydried powders for inhalation. J Pharm Sci 2008, 97:287?02. 34. Srichana T, Brain A, Marriott C, Martin GP: A study of drug-carrier interactions in dry powder inhaler formulations applying the Andersen cascade impactor, X-ray microanalysis and time of flight aerosol beam spectrometry (TOFABS). Chem Pharm Bull 2000, 48:167?74. 35. Scalia S, Salama R, Young P, Traini D: Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. J Microencap 2012, 29:225?33.Daman et al. DARU Journal of Pharmaceutical Sciences 2014, 22:50 darujps/content/22/1/Page 9 of36. Yu J, Chien YW: Pulmonary drug delivery: physiologic and mechanistic aspects. Crit Rev Ther Drug Carrier Syst 1997, 14:395?53. 37. Bosquillon C, Lombry C, Preat V, Vanbever R: Comparison of particle sizing approaches inside the case of inhalation dry powders. J Pharm Sci 2001, 90:2032?041. 38. Zeng XM, Martin GP, Marriott C: Particulate Interactions in Dry Powder Formulation for Inhalation. London: Taylor Francis; 2000.doi:10.1186/2008-2231-22-50 Cite this article as: Daman et al.: Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying approach. DARU Journal of Pharmaceutical Sciences 2014 22:50.Submit your next manuscript to BioMed Central and take complete advantage of:?Practical on line submission ?Thorough peer assessment ?No space constraints or colour figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus and Google Scholar ?Research that is freely available for 5-HT4 Receptor custom synthesis redistributionSubmit your manuscript at biomedcentral/submit
Ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) can be a phenolic acid that’s discovered abundantly within the hemicellulose of plant cell walls, where it cross-links arabinoxylan molecules through arabinose residues, in addition to other nNOS Species people, within the Poaceae plant family members. FA has prospective therapeutic applications due to its antioxidant and anti-inflammatory properties [1]. FA moderates oxidative stress and inflammation in Alzheimer’s illness [2,3] too as reduces DNA damage from irradiation in mammalian cells [4]. FA is also applied to make the flavoring agent vanillin by microbial conversion [5,6]. Enzymatic production of FA from biomass has been reported previously [7,8], and feruloyl esterase (FAE) has been identified as a crucial enzyme in the procedure [9]. FAE is found in Aspergillus species like A. niger [10], A. awamori [11,12], along with a. oryzae [13]. FAEs are classified into four subgroups, A, B, C, and D, according to their amino acid sequences and substrate specificity [13]. Additionally, FAEs from Streptomyces species have also been reported [14,15], even so, genetic information on Streptomyces FAEs relative to FAE activity is still unclear.Streptomyces is actually a widely utilized bacterium and the genomic sequences of many Streptomyces species have been identified [16,17]. Various genes that code for beneficial enzymes happen to be identified within the Streptomyces genome which can be.
